We constructed a risk model based on the expression levels of these RBPs and found that ADAT2, C2orf15, SRP72, PAICS, RBMS3, APOBEC3G, NOA1, and ACO1 could be used for risk assessment in terms of breast cancer prognosis (Fig. 4A–C). The gene discussed is ACO1; the disease is breast carcinoma.